Hansa Biopharma announces closing of €115 million licensing transaction with SERB Pharmaceuticals for Idefirix in Europe and MENA
LUND, Sweden, July 1, 2026, 09:24 GMT-04
HANSA-BIOPHARMA-SERB
Read full article →
Category
Healthcare
This category brings together content related to healthcare, medicine, clinical research, healthcare services, medical devices, therapies and the development of solutions for the sector. Sector classification by EMSF Lisboa.
SkylineDx's Merlin CP-GEP Granted FDA Breakthrough Device Designation, Building on Exclusive NCCN Recognition in Melanoma Care
ROTTERDAM, Netherlands and SAN DIEGO, July 1, 2026, 03:00 GMT-04
SkylineDx
Read full article →
SciBase Submits FDA 510(k) to Expand Nevisense into the Largest Skin Cancer Market
STOCKHOLM, July 1, 2026, 02:53 GMT-04
SCIBASE-submit-FDA
Read full article →
Active Care Group announces landmark development of new private specialist rehabilitation hospital in Stoke Mandeville
STOKE MANDEVILLE, England, July 1, 2026, 19:01 GMT-04
ACTIVE-CARE-new-hosp
Read full article →
Magnetic Resonance Imaging (MRI) Market to Reach USD 10.2 Billion by 2036 as AI Reconstruction and Low-Helium Systems Improve Imaging Efficiency | FMI
NEWARK, Del., June 30, 2026, 11:30 GMT-04
FMI-Magnetic-Resonanc
Read full article →
Long-Acting Drugs Market to Reach US$ 13.3 Billion by 2033 Expands Amid Advances in Sustained Drug Delivery and Chronic Disease Management - Persistence Market Research
LONDON, June 30, 2026, 10:46 GMT-04
Persistence-Market-Re
Read full article →
Warm Autoimmune Hemolytic Anemia Market to Observe Stunning Growth at a 14.4% CAGR During the Forecast Period (2026-2036) Due to the Emergence of Novel Drug Classes Such as FcRn Inhibitors, BTK Inhibitors, BAFF-R, and Others | DelveInsight
LAS VEGAS, June 30, 2026, 10:31 GMT-04
DELVEINSIGHT
Read full article →
Body Fluid Analysis Market worth $3.65 billion by 2031 | MarketsandMarkets™
DELRAY BEACH, Fla., June 30, 2026, 10:30 GMT-04
MARKETSANDMARKETS
Read full article →
Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis
NAGOYA, Japan, June 30, 2026, 10:00 GMT-04
Kowa-FDA-PBC
Read full article →
Shantha Biologics Announces Cartridge Fill-Finish Collaboration
HYDERABAD, India, June 30, 2026, 09:13 GMT-04
SHANTHA-BIOLOGICS-con
Read full article →
New Human Study in Nature's Scientific Reports Finds Candela's Nordlys® Non-Ablative Fractional Laser Reverses the Skin's Epigenetic Signature of Aging
MARLBOROUGH, Mass., June 30, 2026, 09:07 GMT-04
Candela-Corporation
Read full article →
Cumulus Neuroscience Announces Publication in Frontiers in Digital Health Demonstrating the NeuLogiq® Platform Is Feasible and Usable for At-Home Cognitive and EEG Assessment in People Living with Mild Alzheimer's Disease Dementia
BELFAST, Northern Ireland and DUBLIN, June 30, 2026, 09:00 GMT-04
CUMULUS-NEUROSCIENCE
Read full article →
Skyhawk Therapeutics Releases Twelve-Month cUHDRS Subcomponent Results from its Phase 1/2 Clinical Trial of SKY-0515 in Huntington's Disease
BOSTON, June 30, 2026, 07:05 GMT-04
Skyhawk-Therapeutics
Read full article →
CU Medicine Ranked World No. 2 in Gastroenterology & Hepatology
HONG KONG, June 30, 2026, 05:52 GMT-04
CUHK-RANKED
Read full article →
Salt Medical Achieves ISO 13485 Certification, Reinforcing Its Position as a Full-Lifecycle Partner for Medical Device Companies
GALWAY, Ireland, June 30, 2026, 04:00 GMT-04
Salt-Medical
Read full article →
New clinical and real-world evidence on Lecanemab to be presented at AAIC conference 2026
STOCKHOLM, June 30, 2026, 02:53 GMT-04
BioArctic-Lecanemab
Read full article →
IGEL Appoints James Millington as Field CTO for Healthcare in EMEA
LONDON, June 29, 2026, 13:53 GMT-04
IGEL-Healthcare
Read full article →
Nephrotic Syndrome Market Set for Robust Growth During the Forecast Period (2026-2036), Driven by Emerging Therapies and Expanding Research | DelveInsight
LAS VEGAS, June 29, 2026, 10:31 GMT-04
DELVEINSIGHT-RESEARCH
Read full article →
Therapeutic Contact Lenses Market to Reach USD 35.2 Billion by 2036 Driven by Advanced Corneal Care, Drug Delivery Innovation, and Expanding Ophthalmic Procedures
NEWARK, Del., June 29, 2026, 10:01 GMT-04
FUTUREMARKETINSIGHTS
Read full article →
TrilliumBiO and The LAM Foundation Partner to Advance LAM Awareness and Education
ROCKVILLE, Md. and CINCINNATI, June 29, 2026, 09:04 GMT-04
TrilliumBiO-LAM
Read full article →